4//SEC Filing
Burke Steven Keith 4
Accession 0001562180-23-000830
CIK 0001517022other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:14 PM ET
Size
7.7 KB
Accession
0001562180-23-000830
Insider Transaction Report
Form 4
Burke Steven Keith
SVP, Chief Medical Officer
Transactions
- Award
Common Stock
2023-01-31+196,200→ 615,716 total - Award
Stock Option (Right to buy)
2023-01-31+294,300→ 294,300 totalExercise: $0.63Exp: 2033-01-31→ Common Stock (294,300 underlying)
Footnotes (3)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
- [F2]Includes 1,500 shares of the Issuer's common stock purchased on December 30, 2022 under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.
- [F3]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001619834
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:14 PM ET
- Size
- 7.7 KB